Clinical Trial Update: Osia 2 Pediatric Expansion Study [NA]

View source ↗

Summary

Osia 2 pediatric expansion trial by Cochlear has completed, with results posted on June 5, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conductive Hearing Loss
• Mixed Hearing Loss
• Unilateral Hearing Loss

Drugs mentioned

• Osia 2

Snippet

Sponsor: Cochlear | Conditions: Mixed Hearing Loss, Single-Sided Deafness | NA | Status: COMPLETED | Results posted: 2024-06-05